Endocrinology / diabetes clinical trials recruiting in Texas

504 recruiting endocrinology / diabetes trials match in Texas. Showing 20.

• ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsRecruiting

  Phase 1 / Phase 2 · Immatics US, Inc. · Houston, Texas

• ACT Intervention for Type 2 Diabetes Management for Rural and Underserved CommunityRecruiting

  N/A · Sam Houston State University · Conroe, Texas

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Recruiting

  Phase 3 · AstraZeneca · Austin, Texas

• Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaRecruiting

  Phase 2 · National Cancer Institute (NCI) · Dallas, Texas

• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruiting

  Phase 2 · Eli Lilly and Company · Houston, Texas

• A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist UseRecruiting

  Phase 3 · Vanda Pharmaceuticals · Los Angeles, California

• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRecruiting

  Phase 2 · Eli Lilly and Company · Austin, Texas

• Comprehensive Outcomes for After Cancer HealthRecruiting

  N/A · Pack Health · Houston, Texas

• Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III TrialRecruiting

  Phase 3 · M.D. Anderson Cancer Center · Houston, Texas

• A Study to Investigate APL-5125 in Adults With Advanced Solid TumorsRecruiting

  Phase 1 / Phase 2 · Apollo Therapeutics Ltd · Dallas, Texas

• Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral AdiposityRecruiting

  N/A · University of Texas Southwestern Medical Center · Dallas, Texas

• Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsRecruiting

  Phase 1 · Whitehawk Therapeutics, Inc. · Austin, Texas

• A Study of MGC028 in Participants With Advanced Solid TumorsRecruiting

  Phase 1 · MacroGenics · San Antonio, Texas

• A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' DiseaseRecruiting

  Phase 2 · Immunovant Sciences GmbH · Dallas, Texas

• Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyRecruiting

  N/A · M.D. Anderson Cancer Center · Dallas, Texas

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Dallas, Texas

• Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)Recruiting

  N/A · Jaeb Center for Health Research · San Antonio, Texas

• Study of CP-383 in Patients With Advanced or Metastatic Solid TumorsRecruiting

  Phase 1 / Phase 2 · Tasca Therapeutics · Dallas, Texas

• Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)Recruiting

  Phase 3 · Genelux Corporation · Houston, Texas

• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainRecruiting

  Phase 3 · Novo Nordisk A/S · Dallas, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.